United Therapeutics (UTHR) Exchange Rate Effect (2009 - 2017)
United Therapeutics' (UTHR) quarterly Exchange Rate Effect came in at -$200000.0 in Q3 2017, up 80.0% year-over-year from -$111111.1 in Q3 2016, and little changed quarter-over-quarter from -$200000.0 in Q4 2016.
Analysis
United Therapeutics (UTHR) Exchange Rate Effect (2009 - 2017) Analysis & Trends
United Therapeutics has disclosed Exchange Rate Effect across 9 years of filings, most recently posting -$200000.0 for Q3 2017.
- In Q3 2017, Exchange Rate Effect rose 80.0% year-over-year to -$200000.0; the TTM figure through Dec 2017 stood at -$1.4 million (up 53.33% YoY), while the FY2017 annual figure was $200000.0, up 106.67% from the prior year.
- Exchange Rate Effect came in at -$200000.0 for Q3 2017 at United Therapeutics, roughly flat from -$200000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.5 million in Q2 2015 to a low of -$3.1 million in Q1 2015.
- Average Exchange Rate Effect over 5 years is -$742294.1, with a median of -$295000.0 recorded in 2013.
- The largest YoY upside for Exchange Rate Effect was 374.68% in 2015 against a maximum downside of 1912.99% in 2015.
- Over 5 years, Exchange Rate Effect stood at -$295000.0 in 2013, then slumped by 892.54% to -$2.9 million in 2014, then surged by 45.36% to -$1.6 million in 2015, then soared by 87.5% to -$200000.0 in 2016, then changed by 0.0% to -$200000.0 in 2017.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were -$200000.0 in Q3 2017, -$200000.0 in Q4 2016, and -$1.0 million in Q3 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 5.00 Mn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -7.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -37.00 Mn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | -18.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -4.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 11.62 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | -84,000.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | -200,000.00 |
| Dec 31, 2016 | -200,000.00 |
| Sep 30, 2016 | -1.00 Mn |
| Jun 30, 2016 | -2.20 Mn |
| Mar 31, 2016 | 400,000.00 |
| Dec 31, 2015 | -1.60 Mn |
| Sep 30, 2015 | -2.10 Mn |
| Jun 30, 2015 | 1.50 Mn |
| Mar 31, 2015 | -3.10 Mn |
| Dec 31, 2014 | -2.93 Mn |
| Sep 30, 2014 | -1.03 Mn |
| Jun 30, 2014 | 316,000.00 |
| Mar 31, 2014 | -154,000.00 |
| Dec 31, 2013 | -295,000.00 |
| Sep 30, 2013 | 817,000.00 |
| Jun 30, 2013 | 90,000.00 |
| Mar 31, 2013 | -931,000.00 |
| Dec 31, 2012 | 83,000.00 |
| Sep 30, 2012 | 300,000.00 |
| Jun 30, 2012 | -422,000.00 |